Stockholders' Equity - Summary of Non-Vested Options (Detail) |
3 Months Ended |
|---|---|
|
Feb. 29, 2020
$ / shares
shares
| |
| Share-based Payment Arrangement [Abstract] | |
| Non-vested at November 30, 2019 Shares | shares | 125,234 |
| Granted, Shares | shares | 44,969 |
| Vested, Shares | shares | (62,083) |
| Non-vested at February 29, 2020 Shares | shares | 108,120 |
| Non-vested at November 30, 2019, Weighted Average Grant-Date Fair Value | $ / shares | $ 4.70 |
| Granted, Weighted Average Grant-Date Fair Value | $ / shares | 5.03 |
| Vested, Weighted Average Grant-Date Fair Value | $ / shares | 4.51 |
| Non-vested at February 29, 2020, Weighted Average Grant-Date Fair Value | $ / shares | $ 4.95 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Gross number of share options (or share units) granted during the period. No definition available.
|
| X | ||||||||||
- Definition The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of non-vested options outstanding. No definition available.
|
| X | ||||||||||
- Definition Weighted average grant-date fair value of non-vested options outstanding. No definition available.
|
| X | ||||||||||
- Definition Number of options vested. No definition available.
|
| X | ||||||||||
- Definition Weighted average grant-date fair value of options vested. No definition available.
|